№1
Empagliflozin mitigates type 2 diabetes‐associated peripheral neuropathy: a glucose‐independent effect through AMPK signalingNoha F. Abdelkader, Marawan A. Elbaset, Passant E. Moustafa, Sherehan M. Ibrahim
DOI: 10.1007/s12272-022-01391-5
9-29
№2
Modern possibilities of effective nephroprotection in patients with diabetes Cherenko M. S.
30-37
№3
Update of EASD congress – 2022
38-39
№4
Conference with international participation«Topics of modern diabetology»: conference update
40-42
№5
Road map of a patient with type 2 diabetesMankovsky B. M., Sayenko Ya. A
DOI: https://doi.org/10.57105-2415-7252-2022-5-05
43-47
№6
Cardiometabolic medicine: a cardiologist’s perspective Marushko E. Yu.
48-49
№7
Prescription algorithm for hypoglycemic medications for the patients with type 2 diabetes Sayenko Ya. A.
50-53
№8
Modern approaches to treatment of obesity Cherenko M. S.
54-58
№9
Possibilities of prevention and treatment of cognitive dysfunction in people with diabetesMankovsky B. M.
59-71
№10
Аtlas «Diabetic neuropathy: an underestimated complication»
72
№11
Creations of artists with Alzheimer’s disease
73
Підписатись на розсилку